Niagen Bioscience shares fall 1.15% intraday after announcing Tru Niagen debut at Equinox Hotel New York.

Niagen Bioscience, Inc. declined 1.15% in intraday trading, with the company announcing the debut of Tru Niagen® as an in-room amenity at the Equinox Hotel New York, and Niagen IV, now available at the hotel's spa through NutriDrip. This partnership underscores the company's commitment to growing consumer access and driving brand strength.